STAT April 17, 2024
Ed Silverman

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is maple bourbon. Remember that no prescription is required. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day, and please do stay in touch…

Eli Lilly reported positive results for its obesity drug Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market, STAT...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Pepper Bio spices up pipeline with $135M deal for G1 Therapeutics' CDK4/6 inhibitor
BIO survey to elucidate US biopharma's reliance on Chinese CDMOs amid decoupling threats
Lilly uses Mounjaro millions to hunt for biotech partners
FTC cracks down on drug patents
Methods To Alter Cellular Gene Expression

Share This Article